跳至主要内容
临床试验/ACTRN12610000033044
ACTRN12610000033044已完成4 期

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone for reduction in agitation.

Federal University of Tocantins0 个研究点目标入组 150 人开始时间: 2010年1月12日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Any subject in agitation, between 18 and 50 years of age, by bipolar or psychotic disorder by Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR criteria), Overt Agitation Severity Scale Total Score (OASS) equal or under 20 and Overt Aggressive Scale (OAS) with equal or less 4 positive itens.

排除标准

  • Disorders due to drug abuse, organic disorder, anxiety or personality disorder by Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR criteria), no concordance to research, incapable to proceed all steps and not stable clinical disease.

研究者

发起方
Federal University of Tocantins

相似试验